To Compare effects of NEFOPAM HYDROCHLORIDE and TRAMADOL HYDROCHLORIDE for Postoperative Pain relief in patients undergoing orthopaedics surgery

The effects of NEFOPAM HYDROCHLORIDE and TRAMADOL HYDROCHLORIDE on Postoperative Pain in patients undergoing long bone fracture fixations : A Randomised study

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/08/020896

Enrollment

184

Registered

2019-08-26

Start date

Unknown

Completion date

Unknown

Last updated

2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: S00-T88- Injury, poisoning and certain other consequences of external causes

Interventions

Intervention1: NEFOPAM HYDROCHLORIDE (20mg): To compare effects of NEFOPAM HYDROCHLORIDE and TRAMADOL HYDROCHLORIDE for Postoperative Pain relief after orthopaedics surgery Intervention2: TRAMADOL HY

Eligibility

Inclusion criteria

Inclusion criteria: 1) All patients undergoing long bone fracture fixations. 2) Age between 18-60 years

Exclusion criteria

Exclusion criteria: 1) Contraindications for NEFOPAM HYDROCHLORIDE or TRAMADOL HYDROCHLORIDE use. 2) Severe Cardiac disease, Renal or Hepatic insufficiency, Glaucoma, Mentally unstable, drug addicts. 3) Patients on Epidural analgesia during/after surgery. 4) Patients where pain in the operated extremity may be attributed to the some other local cause. 5) Patients not willing to participate in the study.

Design outcomes

Primary

Measure	Time frame
To Compare the analgesic effects of NEFOPAM HYDROCHLORIDE and TRAMADOL HYDROCHLORIDE on Postoperative Pain in patientTimepoint: 1 year	—

Secondary

Measure	Time frame
drug dose effect side effect Timepoint: 12 months	—

Countries

India

Contacts

Public ContactDr Ravi Dholariya

Teerthankar Mahaveer Medical Collage

hudanajamul@gmail.com9837119336

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026